Trials / Completed
CompletedNCT01118572
A Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain Patients
A Phase III Study of YM177 (Postoperative Pain) -- An Etodolac- and Placebo-controlled, Multicenter, Double-blind, Group Comparison Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain Patients --
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 616 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Aim of the study is to compare efficacy and safety of YM177 with placebo and etodolac in patients with postoperative pain.
Detailed description
To verify the superiority to placebo and the noninferiority to etodolac of YM177 in terms of efficacy assessment in patients with postoperative pain. Also, to compare them in terms of safety assessment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM177 | oral |
| DRUG | etodolac | oral |
| DRUG | Placebo | oral |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-11-01
- Completion
- 2010-11-01
- First posted
- 2010-05-06
- Last updated
- 2014-10-15
Locations
8 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01118572. Inclusion in this directory is not an endorsement.